Posicor
On June 20, 1997, the FDA approved Posicor despite findings from a congestive heart failure study suggesting that it might fatally disrupt heart rhythm (arrhythmia) when used with other drugs. The 2,400-patient clinical study found that 142 patients suddenly died after taking either Posicor or a placebo. The patients given Posicor died at a rate about 10% greater than those who took a comparator.
Six months after approving Posicor, the FDA advised doctors of the pill's "life-threatening" danger. The agency announced that it had "received reports of dangerously lowered heart rates in about 20 patients." Roche, the manufacturer, thereafter agreed to change the label advising that Posicor should not be taken in combination with cholesterol-lowering drugs. Click on FAQ on Arrhythmia: Posicor, to learn more about this issue.
On June 8, 1998, after further reported complaints, Roche announced Posicor's withdrawal. Before it was removed from the market, Posicor caused multiple injuries and 24 deaths by interacting dangerously with other medications. Today, doctors suspect that Posicor may responsible in as many as 143 deaths.
If you or a loved one has suffered an injury as a result of taking any drug or supplement, call Littman & Babiarz, Attorneys at Law now at 607-277-7527 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.
<< back
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
